Atlas Trials

Inhalations of Ultra-low Doses of Melphalan for the Treatment of Non-cystic Fibrosis Bronchiectasis

Clinical trial NCT04278040 · UNKNOWN

Trial details

NCT number
NCT04278040
Sponsor
Federal State Budgetary Institution, Pulmonology Scientific Research Institute
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-cystic Fibrosis Bronchiectasis
Start date
2018-06-20
Primary completion
2021-12-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.